Call for a free consultation
866-798-0737
The Law Offices of Tyler & Peery

No antidote for bleeding makes Pradaxa a 'truly defective drug'

As Jef Feeley and Margaret Cronin Fisk report for Bloomberg Businessweek, hundreds of patients who suffered bad side effects from taking Pradaxa to prevent a stroke have sued drug maker Boehringer Ingelheim, which has made more than $1 billion in sales off Pradaxa since bringing the drug to market.

Pradaxa has been marketed as a safe alternative to Coumadin, a blood thinner that the FDA approved for use decades ago. The generic name for the drug Coumadin is "warfarin," which was approved back in 1954.

Yet, at this time, there is no way to reverse bleeding for patients on Pradaxa as compared to patients on Coumadin, prompting one attorney representing injured patients and their families to say that Pradaxa is a "truly defective drug," as Feeley and Fisk report.

It's defective because there's no antidote. Bleeding, in turn, can become uncontrollable and lead to a patient's death.

There are cases pending against Boehringer Ingelheim in state and federal courts across the country.

Source: Boehringer Sued by Hundreds Over Bleeding Tied to Pradaxa

No Comments

Leave a comment
Comment Information

Proven Record Of Results

Email us for response

Contact Us For Answers

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

The Law Offices of Tyler & Peery
5822 W Interstate 10
San Antonio, TX 78201

Toll Free: 877-319-2801
Fax: 210-736-9197
Map & Directions